Global Defibrillator Market Growth, Analysis, Trends, Share, Size, Forecast till 2026
This research report will give you deep insights about the defibrillator market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 115 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market size, market revenue, forecast, COVID-19 impact analysis, SWOT analysis, etc.
The global defibrillator market is likely to expand considerably
in the coming years due to the increasing incidence of out of hospital cardiac
arrests. According to a report published by Fortune Business Insights, titled “Defibrillator: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 9,836.8
Mn in 2018. Fortune Business Insights states that the market will be valued at
US$ 14,806.4 Mn by 2026, thereby exhibiting a CAGR of 5.3% during the forecast
period.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/defibrillator-market-100950
Some of the key players in the
global Defibrillator
Market:
·
Asahi
Kasei Corporation
·
Philips
Healthcare
·
Defibtech,
LLC.
·
Cardiac
Science
·
Stryker
·
CU
Medical System Inc.
·
Medtronic
Boston Scientific Corporation
·
Biotronik
·
LivaNova
Plc,
·
Abbott.
Boston Scientific Proposes a
Defibrillator with 70% More Pacing Options
Boston Scientific receives FDA approval for its newest range of defibrillators,
designed to better patient care. The company received approvals for Dynagen
Mini and Inogen Mini, along with Dynagen X4 and Inogen X4. The company claims
that the X4 lines of defibrillators offer 70% more pacing options for gathering
elevated threshold levels.
The
size of these devices are what differentiates them from its counterparts and it
has created a rising uptake within end users. The company has submitted on its
website that these devices are approximately 20% smaller than the existing
devices, produced by its counterparts. The approvals for Boston Scientific’s
latest devices is likely to enable the growth of the global market in the
forthcoming years.
Some of the leading companies that are operating in the global defibrillator
market are Asahi Kasei Corporation, Philips Healthcare, Defibtech, LLC.,
Cardiac Science, Stryker, CU Medical System Inc., Medtronic Boston Scientific
Corporation, Biotronik, LivaNova Plc and Abbott.
About Us:
Fortune Business Insights™ offers expert corporate analysis
and accurate data, helping organizations of all sizes make timely decisions. We
tailor innovative solutions for our clients, assisting them address challenges
distinct to their businesses. Our goal is to empower our clients with holistic
market intelligence, giving a granular overview of the market they are
operating in. Our reports contain a unique mix of tangible insights and
qualitative analysis to help companies achieve sustainable growth. Our team of
experienced analysts and consultants use industry-leading research tools and
techniques to compile comprehensive market studies, interspersed with relevant
data.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: mailto:sales@fortunebusinessinsights.com
Comments
Post a Comment